Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Immuno-oncology Education Center
Learn about the latest advances in Immuno-oncology. Download webinars, white papers, case studies and blogs.
Xcellerate® Informatics Suite
Successful clinical trials begin and end with the RIGHT data. Uncover new possibilities for your clinical trials with Xcellerate®, a fully integrated informatics platform. ONE comprehensive platform. UNPARALLELED RESULTS.
Genomic approaches & applications for rare disease and orphan drug development | August 23, 11 a.m. EDT
Register for the webinar
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
ELISPOT Assay: A Powerful Tool in Vaccine Development
Learn about benefits and applicability across multiple immunology disciplines. Read the blog.
Proactive risk management for ICH E6 compliance
Understand the recent changes to the ICH E6 guideline. Leverage a three-tier strategy.
Assessing Abuse Potential: Regulatory Environment & Challenges. Watch the Webinar Recording Now.
Save time and money by using a single BioA and central lab services provider.
Bundling these services can result in significant cost savings and faster turnaround times from study start through reports and data transfers. Learn more.
New Approaches to Assessing Cardiac Drug Safety: Updates on ICH E14 and Moving Beyond Thorough QT Testing
Immuno-oncology and the role of biomarkers, companion and complementary diagnostics
Learn more about how the use of a variety of biomarkers, companion diagnostics (CDx) and complementary diagnostics has powered the recent evolution of immunotherapies and their potential applications.
Introducing biosimilar CMC analytical master files
Innovative & invaluable solutions for biosimilar development. Pre-developed, risk-mitigated biosimilarity assessment, testing solutions, data evaluation and consultation.
The diabetic heart: A focus on heart failure recording now available
Hear an insightful discussion on how certain molecular classes impact CV outcomes for patients with type 2 diabetes along with strategies for testing new therapeutic, paradigm-modifying treatment modalities.
Going Virtual: Evolving Real World Evidence Study Design for Speed, Flexibility and Lower Cost
September 19, 11 a.m. EDT. Register now.
Have you visited the NASH Education Center?
We’re pleased to announce the launch of the NASH Education Center. Access the latest thoughts from experts through webinars, case studies, blogs, info sheets and scientific articles.